Cancer Research Archives - Page 7 of 7

August 16, 2024
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
June 29, 2024
Grail spin-out from Illumina completed June 2024 after EU regulatory order
June 29, 2024 — cyberinktimes.com — On June 24, 2024, a significant development occurred in the biotechnology sector as GRAIL, Inc., a…
June 20, 2024
FDA Approves Imetelstat for Myelodysplastic Syndromes
June 20, 2024 — cyberinktimes.com — The FDA approved a new cancer drug on June 15, 2024. It works by attacking the…
May 15, 2024
Moderna Develops Cancer Vaccine Targeting KRAS Gene Mutations Successfully
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
April 22, 2024
FDA Approves First Drug Specifically for Children with Rare Brain Cancer
The U.S. Food and Drug Administration announced on April 15, 2024 that it has approved tovorafenib, marketed under the name Ojemda, as…
March 20, 2024
Renowned Physician Advances Cancer Research with Groundbreaking Techniques
On March 15, 2024, the field of oncology paused to acknowledge the lifelong contributions of Dr. Frederick R. Appelbaum, an American physician‑researcher…
November 15, 2023
AbbVie Pays $10.1B for ImmunoGen ADC Platform
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
September 21, 2023
September 2023 death records show cancer as recurring cause.
In the comprehensive catalog of notable deaths in September 2023, a uniform structure prevails. Each entry consists of a name, age, nationality,…
August 16, 2023
New Cancer Drug Forces Immune Cells to Attack Myeloma
On August 15, 2023, regulators in the United States and the European Union granted approval to talquetamab, a therapeutic that enlists the…
August 16, 2023
New Drug Forces Immune Cells to Attack Multiple Myeloma
August 15, 2023, brought a significant shift for multiple myeloma patients who had exhausted existing therapies. On that date, regulatory authorities in…
August 16, 2023
Talquetamab approved for multiple myeloma in US and EU
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
August 15, 2023
Experimental Medication AOH1996 Enters Phase I Cancer Treatment Trials
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
August 15, 2023
City of Hope drug targets cancer-specific protein, spares healthy cells
/ HTML. 450-560 words. Must not invent quotes etc. Use only facts from source. Let’s list facts: – DNA repair mechanics frustrated…
May 21, 2023
Mutated Enzyme Becomes Target for Cancer Drug Ivosidenib
A medication now in its fifth year of clinical use works by targeting a single altered enzyme present in some patients with…
December 18, 2022
New Medication Approved for Non-Small Cell Lung Cancer Treatment
Tags for Structure. Probably Include a Heading Adagrasib (Krazati) Gains FDA Approval for NSCLC Targeting KRAS G12C On December 15, 2022, the…